Edition:
United Kingdom

Akers Biosciences Inc (AKER.OQ)

AKER.OQ on NASDAQ Stock Exchange Capital Market

0.40USD
16 Feb 2018
Change (% chg)

$0.01 (+1.47%)
Prev Close
$0.39
Open
$0.40
Day's High
$0.40
Day's Low
$0.38
Volume
631,609
Avg. Vol
1,583,411
52-wk High
$2.85
52-wk Low
$0.12

Chart for

About

Akers Biosciences, Inc. develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Company's product offerings and pipeline products focus on delivering diagnostic assistance in a range of healthcare fields/specialties, including... (more)

Overall

Beta: -0.12
Market Cap(Mil.): $7.70
Shares Outstanding(Mil.): 8.90
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.64
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Alpha Capital Anstalt Reports 9.9 Pct Passive Stake In Akers Biosciences

* ALPHA CAPITAL ANSTALT REPORTS 9.9 PERCENT PASSIVE STAKE IN AKERS BIOSCIENCES INC AS ON DECEMBER 21 - SEC FILING Source text (http://bit.ly/2BZ9Q04) Further company coverage:

22 Dec 2017

BRIEF-Akers Biosciences - Accutest Solutions secured new channel partner for sales​

* Akers Biosciences - ‍announces Accutest Solutions a distributor of Akers Bio's breathscan alcohol detector in UK, secured new channel partner for sales​

14 Nov 2017

Earnings vs. Estimates